» Articles » PMID: 23812758

Protective Effect of Bajijiasu Against β-amyloid-induced Neurotoxicity in PC12 Cells

Overview
Publisher Springer
Date 2013 Jul 2
PMID 23812758
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Beta-amyloid peptide (Aβ), a major protein component of senile plaques associated with Alzheimer's disease (AD), is also directly neurotoxic. Mitigation of Aβ-induced neurotoxicity is thus a possible therapeutic approach to delay or prevent onset and progression of AD. This study evaluated the protective effect of Bajijiasu (β- D-fructofuranosyl (2-2) β- D-fructofuranosyl), a dimeric fructose isolated from the Chinese herb Radix Morinda officinalis, on Aβ-induced neurotoxicity in pheochromocytoma (PC12) cells. Bajijiasu alone had no endogenous neurotoxicity up to 200 μM. Brief pretreatment with 10-40 μM Bajijiasu (2 h) significantly reversed the reduction in cell viability induced by subsequent 24 h exposure to Aβ25-35 (21 μM) as measured by MTT and LDH assays, and reduced Aβ25-35-induced apoptosis as indicated by reduced annexin V-EGFP staining. Bajijiasu also decreased the accumulation of intracellular reactive oxygen species and the lipid peroxidation product malondialdehyde in PC12 cells, upregulated expression of glutathione reductase and superoxide dismutase, prevented depolarization of the mitochondrial membrane potential (Ψm), and blocked Aβ25-35-induced increases in [Ca(2+)] i . Furthermore, Bajijiasu reversed Aβ25-35-induced changes in the expression levels of p21, CDK4, E2F1, Bax, NF-κB p65, and caspase-3. Bajijiasu is neuroprotective against Aβ25-35-induced neurotoxicity in PC12 cells, likely by protecting against oxidative stress and ensuing apoptosis.

Citing Articles

Sulfadiazine Exerts Potential Anticancer Effect in HepG2 and MCF7 Cells by Inhibiting TNFα, IL1b, COX-1, COX-2, 5-LOX Gene Expression: Evidence from In Vitro and Computational Studies.

Gomaa M, Gad W, Hussein D, Pottoo F, Tawfeeq N, Alturki M Pharmaceuticals (Basel). 2024; 17(2).

PMID: 38399404 PMC: 10891904. DOI: 10.3390/ph17020189.


Neuroprotective effects of How.: Anti-inflammatory and antioxidant roles in Alzheimer's disease.

Zhang Y, Zhang M Front Aging Neurosci. 2022; 14:963041.

PMID: 36158563 PMC: 9493036. DOI: 10.3389/fnagi.2022.963041.


Effects of Changyu Daotan Decoction on Depression via Restoration of Mice Hippocampus and Alteration of Expression of Relevant Neurotrophic Factors.

Zhang S, Chen Q, Wu L, Sun K, Lan X, Xie X Evid Based Complement Alternat Med. 2022; 2022:5750647.

PMID: 36072406 PMC: 9444404. DOI: 10.1155/2022/5750647.


Therapeutic Effects of Natural Compounds and Small Molecule Inhibitors Targeting Endoplasmic Reticulum Stress in Alzheimer's Disease.

Gao X, Xu Y Front Cell Dev Biol. 2021; 9:745011.

PMID: 34540853 PMC: 8440892. DOI: 10.3389/fcell.2021.745011.


Neuroprotective Effects of OMO within the Hippocampus and Cortex in a D-Galactose and A -Induced Rat Model of Alzheimer's Disease.

Deng S, Lu H, Chi H, Wang Y, Li X, Ye H Evid Based Complement Alternat Med. 2020; 2020:1067541.

PMID: 33101436 PMC: 7569426. DOI: 10.1155/2020/1067541.


References
1.
Devi L, Prabhu B, Galati D, Avadhani N, Anandatheerthavarada H . Accumulation of amyloid precursor protein in the mitochondrial import channels of human Alzheimer's disease brain is associated with mitochondrial dysfunction. J Neurosci. 2006; 26(35):9057-68. PMC: 6675337. DOI: 10.1523/JNEUROSCI.1469-06.2006. View

2.
Son J, Lee J, Lee M, Lee E, Lee K, La S . Rapid quantitative analysis of oxiracetam in human plasma by liquid chromatography/electrospray tandem mass spectrometry. J Pharm Biomed Anal. 2004; 36(1):183-7. DOI: 10.1016/j.jpba.2004.05.010. View

3.
Huang H, Ou H, Hsieh S, Chiang L . Blockage of amyloid beta peptide-induced cytosolic free calcium by fullerenol-1, carboxylate C60 in PC12 cells. Life Sci. 2000; 66(16):1525-33. DOI: 10.1016/s0024-3205(00)00470-7. View

4.
Peng Y, Xing C, Xu S, Lemere C, Chen G, Liu B . L-3-n-butylphthalide improves cognitive impairment induced by intracerebroventricular infusion of amyloid-beta peptide in rats. Eur J Pharmacol. 2009; 621(1-3):38-45. DOI: 10.1016/j.ejphar.2009.08.036. View

5.
Pike C, Kosmoski J, Cribbs D, Glabe C, Cotman C . Structure-activity analyses of beta-amyloid peptides: contributions of the beta 25-35 region to aggregation and neurotoxicity. J Neurochem. 1995; 64(1):253-65. DOI: 10.1046/j.1471-4159.1995.64010253.x. View